Category: Pharma Industry

AstraZeneca Sues Hawaii, Tennessee, Colorado Over 340B Contract Pharmacy Access Laws

September 5, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

AstraZeneca recently filed a series of federal lawsuits challenging three more states' 340B contract pharmacy access laws.

Drugmaker AstraZeneca recently filed three new federal lawsuits challenging new 340B contract pharmacy access laws in Hawaii, Tennessee and Colorado. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appeals Court Panel Grills All Parties in Oral Arguments Over Louisiana’s 340B Contract Pharmacy Access Law

September 3, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

The U.S. 5th Circuit Court of Appeals heard Sept. 2 oral arguments on drug industry challenges to Louisiana's 340B contract pharmacy access law.

A federal appeals court panel in New Orleans yesterday pressed attorneys for the drug industry, Louisiana officials and state health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drugmakers Argue HHS Cannot Reject 340B Rebates in Federal Appeals Court Briefs

September 3, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

Five drug companies recently urged the federal appeals court in Washington, D.C. to overturn a lower court's ruling on 340B rebates.

Five drug companies are pressing a federal appeals court to rule that the 340B statute does not give the government [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Court Extends Deadlines in Drugmakers’ 340B Rebate Appeals

August 28, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

A Washington, D.C. federal appeals court has extended drugmaker filing deadlines and has pushed back oral arguments in litigation surrounding HRSA's authority to approve 340B rebates.

A federal appeals court in Washington, D.C. has extended a filing deadline and postponed oral arguments in the drug industry’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Remained Strong in the Second Quarter of 2025, Filings Show

August 26, 2025 Shannon Young, Associate Editor/Senior Writer 340B Report Views

340B program stakeholders continued to spend big on federal lobbying efforts in the second quarter of 2025.

The 340B program continued to garner strong lobbying attention on Capitol Hill this spring, despite Congress’ focus on a GOP-backed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AstraZeneca Sues Dakotas Over 340B Contract Pharmacy Access Laws

August 26, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

AstraZeneca filed federal lawsuits in North and South Dakota challenging their 340B contract pharmacy access laws.

Drugmaker AstraZeneca recently filed a pair of federal lawsuits seeking to block 340B contract pharmacy access laws in North and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: Updates in Missouri, Nebraska, Oklahoma and Rhode Island

August 26, 2025 Sophie Putka 340B Report Views

Key briefs were filed recently in litigation over state 340B contract pharmacy laws in Missouri, Nebraska, Oklahoma and Rhode Island.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Publishes New FAQ on Controversial 340B Rebate Pilot Program

August 21, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

HRSA recently published an FAQ addressing various stakeholder inquiries about its 340B rebate pilot program.

The Health Resources and Services Administration (HRSA) recently published an FAQ responding to stakeholder questions about its contentious new 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Court Schedules Late-October Oral Arguments for Drugmaker 340B Rebate Appeals

August 21, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

A Washington, D.C. federal appeals court scheduled oral arguments for drugmakers' 340B rebate appeals.

A federal appeals court recently scheduled late-October oral arguments for the pivotal legal battle over 340B rebate models, but hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Six Drugmakers to Refund 340B Covered Entities for Overcharges

August 21, 2025 Shannon Young, Associate Editor/Senior Writer 340B Report Views

Six drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025.

Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live